relative to use of cannabis products for therapeutic purposes by alternative treatment centers.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 5 Sponsors 8

Mar 26, 2026 · Senate

Sen. Gannon Moved Laid on Table, MA, VV; 03/26/2026; SJ 7

Mar 26, 2026 · Senate

Pending Motion Interim Study; 03/26/2026; SJ 7

Mar 18, 2026 · Senate

Committee Report: Referred to Interim Study, 03/26/2026, Vote 3-1; SC 11

Feb 5, 2026 · Senate

Hearing: 02/10/2026, Room 100, SH, 01:50 pm; SC 5A

Jan 7, 2026 · Senate

Introduced 01/07/2026 and Referred to Judiciary; SJ 2

PASSAGE PROBABILITY

26.5% Uncertain

Why this number

Stage base In Committee — base rate 27%, measured from NH's completed sessions
Momentum -1 44/100 from the pace of recorded action
Time since last action -22 198 days quiet
Cosponsors +10 7 signed on
Bipartisan support +9 2 D · 6 R
Sponsor influence +4 93/100

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.